↓ Skip to main content

Tamoxifen in Duchenne muscular dystrophy (TAMDMD): study protocol for a multicenter, randomized, placebo-controlled, double-blind phase 3 trial

Overview of attention for article published in Trials, November 2019
Altmetric Badge

Citations

dimensions_citation
26 Dimensions

Readers on

mendeley
77 Mendeley